United States· US:0310-4600_90a24746-75fb-490b-9e0d-7e33a5d8f00a
BEVESPI AEROSPHERE
A medicinal product containing glycopyrrolate; formoterol fumarate, registered in United States by AstraZeneca Pharmaceuticals LP.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GLYCOPYRROLATE; FORMOTEROL FUMARATE
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110310460012120 AEROSOL, METERED in 1 INHALER (0310-4600-12)
- ndc110310-4600-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrrolate; formoterol fumarate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEVESPI AEROSPHEREAstraZeneca AB, Södertälje
- FinlandBevespi AerosphereAstraZeneca AB
- United KingdomBevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhalerAstraZeneca UK Ltd
- NorwayBevespi AerosphereAstraZeneca AB (2)
- SwedenBevespi Aerosphere 7,2 mikrogram/5 mikrogram Inhalationsspray, suspensionAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bevespi Aerosphere
- Liechtenstein · Bevespi Aerosphere
- Norway · Bevespi Aerosphere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/04b09363-997d-4cea-85b8-c75904ac312a GET /v1/drugs/04b09363-997d-4cea-85b8-c75904ac312a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RESPIRATORY (INHALATION)",
"source": "ndc",
"strength": "9; 4.8",
"substance": "GLYCOPYRROLATE; FORMOTEROL FUMARATE",
"productndc": "0310-4600",
"dosage_form": "AEROSOL, METERED",
"dea_schedule": null,
"strength_unit": "ug/1; ug/1",
"application_number": "NDA208294",
"marketing_category": "NDA"
}See everything about glycopyrrolate; formoterol fumarate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.